journal article·2020-01-01Open access

ZnO/CNT@Fe 3 O 4 induces ROS-mediated apoptosis in chronic myeloid leukemia (CML) cells: an emerging prospective for nanoparticles in leukemia treatment

Amir-Mohammad Yousefi, Ava Safaroghli-Azar, Zahra Fakhroueian, Davood Bashash

Abstract

The advent of nanoparticles revolutionised the drug delivery systems in human diseases; however, their prominent role was highlighted in the cancer-based therapies, where this technology could specifically target cancer cells. Herein, we decided to combine two nanoparticles Fe3O4 and ZnO to fabricate a new anti-cancer nanocomposite. Noteworthy, hydroxylated carbon nanotube (CNT) was used to increase the water-solubility of the compound, improving its uptake by malignant cells. This study was designed to evaluate the anticancer property as well as the molecular mechanisms of ZnO/CNT@Fe3O4 nanocomposite cytotoxicity in CML-derived K562 cells. Our results outlined that ZnO/CNT@Fe3O4 decreased the proliferative capacity of K562 cells through induction of G1 arrest and induced apoptosis probably via ROS-dependent upregulation of FOXO3a and SIRT1. The results of qRT-PCR analysis also demonstrated that while ZnO/CNT@Fe3O4 significantly increased the expression of pro-apoptotic genes in K562 cells, it had no significant inhibitory effect on the expression levels of anti-apoptotic target genes of NF-κB; proposing an attenuating role of NF-κB signalling pathway in K562 cell response to ZnO/CNT@Fe3O4. Synergistic experiment showed that ZnO/CNT@Fe3O4 could enhance the cytotoxic effects of imatinib on K562 cells. Overall, it seems that pharmaceutical application of nanocomposites possesses novel promising potential for leukaemia treatment strategies.
Source: openalex_inverted_index · Quality: baseline

Research context

OpenAlex topics: FOXO transcription factor regulation · Chronic Myeloid Leukemia Treatments · Cell death mechanisms and regulation

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Department of Hematology and Blood Banking, School of Allied Medical Sciences, Shahid Beheshti University of Medical Sciences

School of Chemical Engineering, College of Engineering, Institute of Petroleum Engineering, University of Tehran

References (34)

Show source-provided references
1. 10.1182/blood-2006-01-009210.1182/blood-2006-01-0092 ↗
2. 10.1056/NEJM20010405344140110.1056/NEJM200104053441401 ↗
3. 10.1074/jbc.RA119.00803710.1074/jbc.RA119.008037 ↗
4. 10.1186/s12943-018-0780-610.1186/s12943-018-0780-6 ↗
5. 10.1016/j.drudis.2012.05.01010.1016/j.drudis.2012.05.010 ↗
6. 10.1177/15330346050040040810.1177/153303460500400408 ↗
7. 10.1016/j.biotechadv.2013.10.01310.1016/j.biotechadv.2013.10.013 ↗
8. 10.1021/acsami.6b0493310.1021/acsami.6b04933 ↗
9. 10.1080/17425247.2019.155464710.1080/17425247.2019.1554647 ↗
10. 10.2147/IJN.S14007110.2147/IJN.S140071 ↗
11. 10.1039/C8BM00588E10.1039/C8BM00588E ↗
12. 10.1088/0957-4484/19/29/29510310.1088/0957-4484/19/29/295103 ↗
13. 10.1007/s12274-009-9089-510.1007/s12274-009-9089-5 ↗
14. 10.1016/j.biomaterials.2011.10.08010.1016/j.biomaterials.2011.10.080 ↗
15. 10.1088/0957-4484/26/30/30570210.1088/0957-4484/26/30/305702 ↗
16. 10.1016/B978-0-12-813691-1.00004-X10.1016/B978-0-12-813691-1.00004-X ↗
17. 10.1016/j.molliq.2018.06.09110.1016/j.molliq.2018.06.091 ↗
18. 10.1016/j.jhazmat.2016.04.01410.1016/j.jhazmat.2016.04.014 ↗
19. 10.1016/j.cej.2017.10.17210.1016/j.cej.2017.10.172 ↗
20. 10.1016/j.apsusc.2013.08.01210.1016/j.apsusc.2013.08.012 ↗
21. 10.1038/cddis.2013.35010.1038/cddis.2013.350 ↗
22. 10.1038/sj.emboj.760047610.1038/sj.emboj.7600476 ↗
23. 10.1371/journal.pone.007387510.1371/journal.pone.0073875 ↗
24. 10.1016/j.ijpharm.2018.07.02710.1016/j.ijpharm.2018.07.027 ↗
25. 10.1186/s11671-016-1734-910.1186/s11671-016-1734-9 ↗
26. 10.1016/j.marpolbul.2011.03.00610.1016/j.marpolbul.2011.03.006 ↗
27. 10.1166/jbn.2013.159310.1166/jbn.2013.1593 ↗
28. 10.1242/jcs.09209810.1242/jcs.092098 ↗
29. 10.3390/ijms1402383410.3390/ijms14023834 ↗
30. 10.1177/153303461877030510.1177/1533034618770305 ↗
31. 10.1073/pnas.071214510510.1073/pnas.0712145105 ↗
32. 10.1002/jcb.2867510.1002/jcb.28675 ↗
33. 10.1016/j.biocel.2019.01.00510.1016/j.biocel.2019.01.005 ↗
34. 10.2174/1568009611313999008810.2174/15680096113139990088 ↗